AUT LibraryAUT
View Item 
  •   Open Research
  • AUT Faculties
  • Faculty of Health and Environmental Sciences
  • School of Public Health and Interdisciplinary Studies
  • View Item
  •   Open Research
  • AUT Faculties
  • Faculty of Health and Environmental Sciences
  • School of Public Health and Interdisciplinary Studies
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Nicotinamide Mononucleotide (NMN) as an Anti-aging Health Product – Promises and Safety Concerns

Nadeeshani, H; Li, J; Ying, T; Zhang, B; Lu, J
Thumbnail
View/Open
Journal article (941.0Kb)
Permanent link
http://hdl.handle.net/10292/15010
Metadata
Show full metadata
Abstract
Background

Elderly population has been progressively rising in the world, thus the demand for anti-aging heath products to assure longevity as well as to ameliorate age-related complications is also on the rise. Among various anti-aging health products, nicotinamide mononucleotide (NMN) has been gaining attentions of the consumers and the scientific community.

Aim of review

This article intends to provide an overview on the current knowledge on promises and safety concerns of NMN as an anti-aging health product.

Key scientific concepts of review

Nicotinamide adenine dinucleotide (NAD+) levels in the body deplete with aging and it is associated with downregulation of energy production in mitochondria, oxidative stress, DNA damage, cognitive impairment and inflammatory conditions. However, NMN, as the precursor of NAD+, can slow down this process by elevating NAD+ levels in the body. A number of in vivo studies have indicated affirmative results of therapeutic effects for various age-induced complications with NMN supplementation. One preclinical and one clinical study have been conducted to investigate the safety concerns of NMN administration while a few more human clinical trials are being conducted. As there is a large influx of NMN based anti-aging products on the market, proper clinical investigations are urgently needed to find out the effectiveness and safety of NMN supplementation.
Keywords
Age-induced diseases; Anti-aging; Nicotinamide adenine dinucleotide; Nicotinamide mononucleotide; Supplement
Date
2021
Source
Journal of Advanced Research, 37 (2022), pp. 267–278.
Item Type
Journal Article
Publisher
Elsevier BV
DOI
10.1016/j.jare.2021.08.003
Publisher's Version
https://www.sciencedirect.com/science/article/pii/S2090123221001491
Rights Statement
(C) 2022 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Contact Us
  • Admin

Hosted by Tuwhera, an initiative of the Auckland University of Technology Library

 

 

Browse

Open ResearchTitlesAuthorsDateSchool of Public Health and Interdisciplinary StudiesTitlesAuthorsDate

Alternative metrics

 

Statistics

For this itemFor all Open Research

Share

 
Follow @AUT_SC

Contact Us
  • Admin

Hosted by Tuwhera, an initiative of the Auckland University of Technology Library